Your browser doesn't support javascript.
loading
Results of sleeve gastrectomy conversion to Roux-en-Y gastric bypass on gastroesophageal reflux disease symptoms and proton pump inhibitors use evolution over time.
Benamran, Dorith; Chierici, Andrea; Temime, Victor; Drai, Céline; Iannelli, Antonio.
Affiliation
  • Benamran D; University of Côte d'Azur, Nice, France; Department of Digestive Surgery, Hopital Archet 2, University Hospital of Nice, Nice, France.
  • Chierici A; Department of Digestive Surgery, Hopital Archet 2, University Hospital of Nice, Nice, France.
  • Temime V; University of Côte d'Azur, Nice, France; Department of Digestive Surgery, Hopital Archet 2, University Hospital of Nice, Nice, France.
  • Drai C; University of Côte d'Azur, Nice, France; Department of Digestive Surgery, Hopital Archet 2, University Hospital of Nice, Nice, France.
  • Iannelli A; University of Côte d'Azur, Nice, France; Department of Digestive Surgery, Hopital Archet 2, University Hospital of Nice, Nice, France; Team 8 Hepatic Complications in Obesity, Institut National de la Santé et de la Recherche Médicale, Nice, France; Adipocible Research Study Group, University of Nice
J Gastrointest Surg ; 28(9): 1412-1419, 2024 Sep.
Article in En | MEDLINE | ID: mdl-38852930
ABSTRACT

BACKGROUND:

Although sleeve gastrectomy (SG) is associated with excellent results in the short term, it has been shown that it is plagued by weight regain and new onset or worsening of gastroesophageal reflux disease (GERD). These 2 clinical conditions are currently the 2 most frequent indications for revisional surgery. To date, only a few studies have focused exclusively on GERD. In a selected series of patients complaining of GERD symptoms after SG as a main complaint, we analyzed the efficacy of conversion to Roux-en-Y gastric bypass (RYGB), with a standardized surgical technique.

METHODS:

This is a retrospective study including all consecutive cases of SG to RYGB conversion for GERD not controlled by medical treatment. We excluded all patients undergoing conversion for weight regain without GERD. Quality of life and GERD symptoms were evaluated at outpatient's clinic visits before and after surgery with 2 standardized questionnaires (Gastroesophageal Reflux Disease Questionnaire and Simplified Form 6).

RESULTS:

This study showed that 70% of patients had complete resolution of GERD symptoms and 60% had completely discontinued proton pump inhibitors (PPIs). The conversion to RYGB resulted in a significant decrease in the rate of patients presenting daily symptoms of GERD and use of PPIs (10% and 16.6%, respectively; P < .019) and a dramatic increase in those without symptoms and no need for PPIs (70% and 60%, respectively; P < .001).

CONCLUSION:

Conversion to RYGB is a good option for GERD complications after SG providing a high rate of symptom remission and PPI discontinuation. Conversion to RYGB in the setting of GERD complications after SG improves postoperative outcomes decreasing GERD symptoms and improving quality of life.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Gastric Bypass / Gastroesophageal Reflux / Proton Pump Inhibitors / Gastrectomy Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Gastrointest Surg Journal subject: GASTROENTEROLOGIA Year: 2024 Document type: Article Affiliation country: France Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Gastric Bypass / Gastroesophageal Reflux / Proton Pump Inhibitors / Gastrectomy Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Gastrointest Surg Journal subject: GASTROENTEROLOGIA Year: 2024 Document type: Article Affiliation country: France Country of publication: Netherlands